The Wall Street Journal Torches Trump's Anti-Tylenol Campaign: Whatever Happened to Do No Harm?'
Briefly

The Wall Street Journal Torches Trump's Anti-Tylenol Campaign: Whatever Happened to Do No Harm?'
"After observing that higher rates of autism are likely attributable to broader diagnostic criteria and heightened public awareness, the newspaper put forward a reason to continue recommending pregnant women to use Tylenol: All of this suggests a need for policy caution, which is why the FDA has for many years declined to change the warning label on Tylenol. One reason is because doctors typically advise that pregnant women take acetaminophen as the safest remedy for fever and pain; anti-inflammatory drugs like ibuprofen"
"The FDA acknowledged as much Monday: There can be risks for untreated fever in pregnancy, both for the mother and fetus and there are contrary studies showing no association between autism and acetaminophen. So why the sudden alarm, complete with a presidential presser? The Occam's razor answer is the influence of RFK Jr., who is carrying water for his friends in the plaintiffs bar. A who's-who of lawsuit shops are pushing the Tylenol-autism link in federal court,"
President Donald Trump and Robert F. Kennedy Jr. announced that the FDA will notify physicians that prenatal use of Tylenol can be associated with an increased autism risk and recommended avoiding it during pregnancy. Critics called the claim unproven and suggested litigation interests are motivating the campaign. Observers noted higher autism rates are likely due to broader diagnostic criteria and stressed FDA caution in changing Tylenol warnings. Medical guidance typically favors acetaminophen in pregnancy because untreated fever and anti-inflammatory alternatives like ibuprofen can harm fetal development. The FDA acknowledged conflicting studies and risks of untreated fever.
Read at www.mediaite.com
Unable to calculate read time
[
|
]